Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 2
1(50.0%)
Phase 1
1(50.0%)
2Total
Phase 2(1)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT07488975Phase 1Recruiting

Developing Microbial Therapy for MASLD: From Mechanism to Clinical Validation

Role: lead

NCT06578143Phase 2Not Yet Recruiting

Effects of Synbiotics on Obesity

Role: lead

NCT06363864Not Yet Recruiting

Investigation of Metabolomics Differences Between Metabolic Syndrome and Healthy Individuals in Taiwan

Role: lead

All 3 trials loaded